SFEBES2019 POSTER PRESENTATIONS Thyroid (51 abstracts)
Amiodarone induced thyroiditis in congenital heart disease – how long should we continue steroids?
Yin Yin 1 , Oluwaseun Anyiam 1 , Felicity Kaplan 1 , Samer Al-Sabbagh 1 , Andrew Solomon 1 , Fausto Palazzo 2 , Karim Meeran 2 & Jalini Joharatnam 1
1East and North Hertfordshire NHS Trust, Stevenage, UK; 2Imperial College Healthcare NHS Trust, London, UK
A 38-year male with background history of Tetralogy of Fallot which had been surgically corrected, presented with symptomatic supraventricular tachycardia in July 2015. This required amiodarone therapy. Thyroid function was normal prior to starting amiodarone. Amiodarone therapy was discontinued in July 2017 when he converted to sinus rhythm. Seven months after stopping treatment, he presented to A&E with signs and symptoms of hyperthyroidism. His TSH was <0.03 mU/l (0.27–4.2), T4 154 pmol/l (12–22) with negative thyroid antibodies. The Burch–Wartofsky score was 35, suggesting an impending thyroid storm. An ultrasound showed thyroiditis with no increased vascularity. He was treated with propylthiouracil 200 mg tds, which was increased thereafter to 300 mg tds and prednisolone 30 mg as well as Lugols iodine. After 6 weeks of this treatment his T4 reduced to 61 pmol/l with TSH of <0.03 mU/l. Prednisolone was discontinued at this stage and within 10 days the T4 was again >154 pmol/l with a TSH<0.03 mU/l. A Tc uptake scan was performed which showed no uptake. Prednisolone 60 mg was commenced and propylthiouracil was increased to 300 mg 6 times daily and continued for 3 months with a dose reduction over time. By the end of July 2018 his thyroid function had come under control (ft4 9.8 pmol/l, TSH 15.3 mU/l). He underwent thyroidectomy in October 2018. There are two types of amiodarone induced thyroiditis. In this case we opted to treat for both simultaneously. This gentleman required a long admission and frequent close discussion with a tertiary centre. At one stage an urgent thyroidectomy was felt to be required, however he eventually began to respond to the combination of longer term steroid treatment and PTU. This case highlights that it is unpredictable how long steroids will be required and close follow up of response is needed to judge when to stop.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more